003022 联泓新科
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.1793.2646.34713.05318.352
总资产报酬率 ROA (%)1.0991.2832.8716.6269.982
投入资产回报率 ROIC (%)1.1921.4153.2237.44311.085

边际利润分析
销售毛利率 (%)19.47516.50116.16020.22225.135
营业利润率 (%)6.0685.0727.66010.54716.744
息税前利润/营业总收入 (%)8.0076.2218.96811.93318.605
净利润/营业总收入 (%)5.2394.2406.73210.71314.586

收益指标分析
经营活动净收益/利润总额(%)87.89525.51938.26679.78780.885
价值变动净收益/利润总额(%)0.75513.843-0.4410.3013.338
营业外收支净额/利润总额(%)-0.199-5.4460.331-0.2880.056

偿债能力分析
流动比率 (X)0.6950.6070.7001.0550.958
速动比率 (X)0.5920.5040.5860.8660.787
资产负债率 (%)64.83659.73954.00947.53745.586
带息债务/全部投入资本 (%)62.34856.71349.76339.75337.684
股东权益/带息债务 (%)56.01571.45993.757140.486154.866
股东权益/负债合计 (%)49.96262.09877.453103.825114.954
利息保障倍数 (X)4.1044.4096.9928.42610.051

营运能力分析
应收账款周转天数 (天)8.4249.2869.8257.8487.897
存货周转天数 (天)49.19744.95941.60034.92932.050